| Literature DB >> 24855271 |
Yusuke Sato1, Shigekatsu Maekawa2, Ryohei Ishii3, Masashi Sanada4, Teppei Morikawa5, Yuichi Shiraishi6, Kenichi Yoshida4, Yasunobu Nagata4, Aiko Sato-Otsubo4, Tetsuichi Yoshizato4, Hiromichi Suzuki4, Yusuke Shiozawa4, Keisuke Kataoka4, Ayana Kon4, Kosuke Aoki4, Kenichi Chiba6, Hiroko Tanaka7, Haruki Kume2, Satoru Miyano8, Masashi Fukayama5, Osamu Nureki3, Yukio Homma9, Seishi Ogawa10.
Abstract
Cushing's syndrome is caused by excess cortisol production from the adrenocortical gland. In corticotropin-independent Cushing's syndrome, the excess cortisol production is primarily attributed to an adrenocortical adenoma, in which the underlying molecular pathogenesis has been poorly understood. We report a hotspot mutation (L206R) in PRKACA, which encodes the catalytic subunit of cyclic adenosine monophosphate (cAMP)-dependent protein kinase (PKA), in more than 50% of cases with adrenocortical adenomas associated with corticotropin-independent Cushing's syndrome. The L206R PRKACA mutant abolished its binding to the regulatory subunit of PKA (PRKAR1A) that inhibits catalytic activity of PRKACA, leading to constitutive, cAMP-independent PKA activation. These results highlight the major role of cAMP-independent activation of cAMP/PKA signaling by somatic mutations in corticotropin-independent Cushing's syndrome, providing insights into the diagnosis and therapeutics of this syndrome.Entities:
Mesh:
Substances:
Year: 2014 PMID: 24855271 DOI: 10.1126/science.1252328
Source DB: PubMed Journal: Science ISSN: 0036-8075 Impact factor: 47.728